fbpx

fda recall

Tag Archive

5 Warning Signs of Abdominal Mesh Complications

5 Warning Signs of Abdominal Mesh Complications

| Medical Malpractice
Most people who suffer from abdominal hernias require a surgical procedure to repair the problem. The surgery heavily relies on a hernia mesh—a surgical implant. Studies show that nearly one-third of the people who undergo hernia surgeries experience some sort of complication.  Those experiencing severe difficulties should file an abdominal mesh lawsuit against specific mesh…Read the article
Benzene Contamination Prompts Sunscreen Recall

Benzene Contamination Prompts Sunscreen Recall

| Napoli Shkolnik News
Under pressure from the Food and Drug Administration, Johnson & Johnson recalled five popular sunscreens which were tainted with benzene, a chemical which can cause serious health problems at even very low levels. The affected aerosol products are Aveeno Protect + Refresh aerosol sunscreen, along with four versions of Neutrogena sunscreen: CoolDry Sport aerosol sunscreen,…Read the article
Penumbra JET 7 Catheters Lawyers

Penumbra JET 7 Catheters Lawyers

| Pharmaceutical Litigation
Typically, strokes are either the deadliest or least deadly cardiovascular episodes. Thanks to the advent of advanced catheters and other medical devices, the stroke survivability rate has increased substantially since the 1990s. However, these devices can frequently do more harm than good. Often, in their rush to build a better mousetrap, device makers take dangerous…Read the article
FDA Issues New Xeljanz Warning

FDA Issues New Xeljanz Warning

| Pharmaceutical Litigation
For the third time in two years, the Food and Drug Administration has issued a safety warning about Pfizer’s powerful and popular arthritis/UC medicine. The latest warning is the strongest and most comprehensive one yet. The FDA says that doses as small as 5mg per day could lead to cancer and heart problems, particularly among…Read the article
FDA Finds Cancer-Causing Agent in Metformin

FDA Finds Cancer-Causing Agent in Metformin

| Pharmaceutical Litigation
The sudden recall of a popular diabetes drug because of NDMA contamination (cancer-causing agent) creates a cloud over the Food and Drug Administration’s entire review process. Time-Cap Labs Inc.’s generic drug is used to treat Type 2 diabetes. Its lower cost makes it a popular alternative to brand-name drugs. When the most recent test results…Read the article
Warned: Non-Medical COVID-19 Treatment Producers

Warned: Non-Medical COVID-19 Treatment Producers

| Pharmaceutical Litigation
The Federal Trade Commission and Food and Drug Administration recently told seven companies to either stop selling certain products or revise their claims. In a mass letter to Vital Silver, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, and The Jim Baker Show, regulators said these…Read the article
Medtronic Recalls Faulty Insulin Pumps

Medtronic Recalls Faulty Insulin Pumps

| Pharmaceutical Litigation
After evidence of a possible life-threatening defect came to light, Medtronic, the medical device giant issued an immediate recall for its MiniMed Insulin Pumps. The recall covers over 300,000 devices which were sold in the United States beginning in June 2017. Medtronic touted these pumps as safe to use for people as young as seven…Read the article
Government Recalls Diabetes Drug

Government Recalls Diabetes Drug

| Pharmaceutical Litigation
After government inspectors found traces of a cancer-causing chemical in Metformin, the Food and Drug Administration ordered a recall of one of the most commonly-prescribed diabetes drugs in America. FDA officials discovered a dangerous chemical, N-Nitrosodimethylamine, in five different Metformin versions. About 34 million Americans have Type 2 Diabetes, and many of them take some…Read the article
Two More Blood Pressure Drugs Added to Ongoing FDA Recall

Two More Blood Pressure Drugs Added to Ongoing FDA Recall

| Pharmaceutical Litigation
The U.S. Food and Drug Administration’s voluntary blood pressure drug recall continues as Torrent Pharmaceuticals Limited announced it is expanding its nationwide recall to include two blood pressure medications that were found to contain trace amounts of a potential cancer-causing carcinogen. The two medications are 3 lots of Losartan Potassium Tablets USP and 2 lots…Read the article